In vivo pharmacokinetics by electron magnetic resonance spectroscopy
β Scribed by Lawrence J. Berliner; Xiaoming Wan
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 312 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
β¦ Synopsis
Low-field in vivo electron spin resonance (ESR) has been used to follow the course of metabolism and distribution of a paramagnetic spin probe, 3-carboxamido-2,2,5,5tetramethylpyrrolidine-I-oxyl. Sprague-Dawley rats (250-300 g) were catheterized in the jugular vein and given serial doses ofthe nitroxide spin probe above. The decrease in the tail blood nitroxide ESR spectrum with the time was followed. This reflects both normal distribution/excretion and a significant metabolic step-reversible reduction of the nitroxide group to its hydroxylamine. The studies serve as important and useful comparisons to the nitroxide reduction kinetics in vitro while offering the important advantage of avoiding those non-steady-state artifacts frequently expected in ex vivo procedures. This study represents the first report of systematic in vivo phannacokinetics of a paramagnetic probe.
π SIMILAR VOLUMES
Proton magnetic resonance spectroscopy ( 1 H MRS) has the potential to provide a noninvasive assessment of hepatic lipid composition. The spectral resolution of in vivo clinical MR data is currently limited by the magnetic field strengths available and by motion artifact. Therefore, interpretation o
Accumulation of triglycerides (TG) in heart tissue has been associated with changes in left ventricular function. Proton magnetic resonance spectroscopy is currently the only noninvasive in vivo method to measure myocardial triglycerides content. The primary aim of this study was to determine if the
## Abstract The therapeutic mechanism of action of lithium (Li) in bipolar disorder is unknown. While Li is presumed to work intracellularly in the brain, the fraction of intracellular Li in the brain in vivo is not known. It has not yet been possible to determine, directly and noninvasively, the i
To better define the survival and cellular composition of human fetal neurotransplants in vivo, we performed quantitative 1 H MRS to determine the concentration of the neuronal amino acid [N-acetylaspartate] within MRI-visible grafts. In all, 71 grafts in 38 patients [24 Parkinson's disease (PD), 14